Mutational Oncology in Clinical Practice

NARecruitingINTERVENTIONAL
Enrollment

20,000

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

January 31, 2032

Conditions
Genome InstabilityGenetic Predisposition to DiseaseGene Rearrangement
Interventions
GENETIC

Diagnostic Test

"In order to proceed with molecular characterization, the tumor sample already taken for histological diagnosis will undergo DNA and RNA extraction, which will be analyzed for qualitative and quantitative evaluation. Based on the quantitative data, the method to be used for profiling will be decided.~Multigenic genomic profiling will be performed for each patient on already taken tumor tissue using different panels depending on the quality and quantity of nucleic acids, in particular the following will be used: comprehensive Genome Profiling (CGP, ≥500 genes), if at least 40 ng of material is available; Profiling with identification of actionable mutations by targeted sequencing with panels of size \>50 genes, if \<40 ng material available."

Trial Locations (1)

Unknown

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER